Why the study?
Does recombinant human erythropoietin improve outcomes in patients with chronic heart failure and anemia?
Does recombinant human erythropoietin improve outcomes in patients with chronic heart failure and anemia?
This review highlights the potential benefits of epoetin treatment for anemia in chronic heart failure, emphasizing the need for large RCTs to confirm morbidity and mortality improvements.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in anemic CHF; leaves open outcome benefits pending large confirmatory RCTs.
The importance of anemia in chronic kidney disease (CKD) has become increasingly well recognized over recent years, as have the benefits of treating anemic CKD patients with recombinant human erythropoietin (rHuEPO, epoetin). As well as reducing the need for blood transfusions and the complications associated with renal failure in CKD patients, rHuEPO treatment decreases patient morbidity and mortality, particularly as a result of cardiovascular disease. The strong correlation between anemia, renal failure and cardiac failure is one that has received much attention recently, with each factor recognized to cause the other to worsen in a 'vicious cycle'. Recent studies have concentrated on the possible benefits of anemia treatment in patients with CHF. Currently available data suggest improvements in CHF symptoms, left ventricular ejection fraction (LVEF) and a reduction of hospitalizations associated with anemia correction through epoetin treatment. Available data from CKD patients suggest that anemia management should begin as early as possible, although the optimal target level for individual patients is as yet unclear. In addition to the currently available evidence, additional large, randomized, controlled studies are required to further define the morbidity/mortality benefits of epoetin treatment in CHF patients with anemia.
No takes yet. Share an insight, caveat, or question.
Besarab et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: